In conclusion, the GLXB herb pair exerts a therapeutic effect on dyslipidemia in ApoE-/- mice by decreasing intestinal cholesterol absorption in ApoE-/- mice by increasing the level of butyric acid, a metabolite of the gut microbiota. Here, APOE is linked to metabolic syndrome.